Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
Open Access
- 10 May 2010
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (10) , 2252-2262
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal functionTransplant International, 2009
- Temporary Porto-Caval Shunt Utility During Orthotopic Liver TransplantationTransplantation Proceedings, 2008
- Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantationClinica Chimica Acta, 2007
- Renal Disease Burden Following Liver TransplantationTransplantation Proceedings, 2006
- EverolimusDrugs, 2006
- Long‐term renal function after liver transplantation is related to calcineurin inhibitors blood levelsClinical Transplantation, 2005
- Chronic Renal Failure after Transplantation of a Nonrenal OrganNew England Journal of Medicine, 2003
- END-STAGE RENAL DISEASE (ESRD) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLTX) USING CALCINEURIN-BASED IMMUNOTHERAPY1Transplantation, 2001
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Banff Schema for Grading Liver Allograft Rejection: An International Consensus DocumentHepatology, 1997